Transient reduction of placental angiogenesis in PAI-1-deficient mice

Physiological Genomics

Volumn 43, Issue 4, 2011, Pages 188-198

  Labied, Soraya ^a   Blacher, Silvia ^a   Carmeliet, Peter ^b   Noël, Agnès ^a   Frankenne, Francis ^a   Foidart, Jean Michel ^a,b   Munaut, Carine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Placentation; Plasminogen activator inhibitor 1

Indexed keywords

CATHEPSIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTOME;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; COMPUTER ANALYSIS; CONTROLLED STUDY; DECIDUA; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENOTYPE; IMAGE ANALYSIS; INNER EAR; LASER CAPTURE MICRODISSECTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA; PLACENTA CIRCULATION; PRIORITY JOURNAL; REPRODUCTION; TROPHOBLAST;

ANIMALS; DECIDUA; EMBRYO IMPLANTATION; FEMALE; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PLACENTA; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPIN E2; TROPHOBLASTS;

MURINAE; MUS;

EID: 79952168212     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00147.2010     Document Type: Article

References (54)

1. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev Biol 250: 358-373, 2002. (Pubitemid 35216421)
2. Bajou K, Maillard C, Jost M, Lijnen RH, Gils A, Declerck P, Carmeliet P, Foidart JM, Noel A. Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23: 6986-6990, 2004. (Pubitemid 39279999)
3. Bajou K, Masson V, Gerard RD, Schmitt PM, Albert V, Praus M, Lund LR, Frandsen TL, Brunner N, Dano K, Fusenig NE, Weidle U, Carmeliet G, Loskutoff D, Collen D, Carmeliet P, Foidart JM, Noel A. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152: 777-784, 2001. (Pubitemid 34280162)
4. Bajou K, Noel A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923-928, 1998. (Pubitemid 28364031)
5. Bajou K, Peng H, Laug WE, Maillard C, Noel A, Foidart JM, Martial JA, DeClerck YA. Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14: 324-334, 2008.
6. Bergese SD, Pelletier RP, Ohye RG, Vallera DA, Orosz CG. Treatment of mice with anti-CD3 mAb induces endothelial vascular cell adhesion molecule-1 expression. Transplantation 57: 711-717, 1994. (Pubitemid 24106769)
7. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932-943, 2002. (Pubitemid 35477371)
8. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 187: 1416-1423, 2002. (Pubitemid 35397496)
9. Can A, Tekelioglu M, Baltaci A. Expression of desmin and vimentin intermediate filaments in human decidual cells during first trimester pregnancy. Placenta 16: 261-275, 1995.
10. Carmeliet P, Collen D. Transgenic mouse models in angiogenesis and cardiovascular disease. J Pathol 190: 387-405, 2000. (Pubitemid 30141384)
11. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 92: 2746-2755, 1993. (Pubitemid 24006540)
12. Cohen M, Meisser A, Bischof P. Metalloproteinases and human placental invasiveness. Placenta 27: 783-793, 2006. (Pubitemid 43905919)
13. Cross JC, Hemberger M, Lu Y, Nozaki T, Whiteley K, Masutani M, Adamson SL. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Mol Cell Endocrinol 187: 207-212, 2002. (Pubitemid 34436950)
14. Curry TE Jr, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev 24: 428-465, 2003. (Pubitemid 37056240)
15. Czekay RP, Aertgeerts K, Curriden SA, Loskutoff DJ. Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J Cell Biol 160: 781-791, 2003. (Pubitemid 36298272)
16. Czekay RP, Loskutoff DJ. Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Exp Biol Med (Maywood) 229: 1090-1096, 2004. (Pubitemid 39602250)
17. Delmar P, Robin S, Daudin JJ. VarMixt: efficient variance modelling for the differential analysis of replicated gene expression data. Bioinformatics 21: 502-508, 2005. (Pubitemid 40310237)
18. Deng G, Curriden SA, Hu G, Czekay RP, Loskutoff DJ. Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin. J Cell Physiol 189: 23-33, 2001.
19. Deussing J, Kouadio M, Rehman S, Werber I, Schwinde A, Peters C. Identification and characterization of a dense cluster of placenta-specific cysteine peptidase genes and related genes on mouse chromosome 13. Genomics 79: 225-240, 2002. (Pubitemid 34124026)
20. Devy L, Blacher S, Grignet-Debrus C, Bajou K, Masson V, Gerard RD, Gils A, Carmeliet G, Carmeliet P, Declerck PJ, Noel A, Foidart JM. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J 16: 147-154, 2002. (Pubitemid 34113008)
21. Floridon C, Nielsen O, Holund B, Sweep F, Sunde L, Thomsen SG, Teisner B. Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies. Placenta 21: 754-762, 2000.
22. Ge Y, Dudoit S, Speed TP. Resampling-based multiple testing for microarray data analysis. Test 12: 1-44, 2003.
23. Gentleman R, Carey V. Bioconductor. R News 2: 11-16, 2002.
24. Georgiades P, Ferguson-Smith AC, Burton GJ. Comparative developmental anatomy of the murine and human definitive placentae. Placenta 23: 3-19, 2002. (Pubitemid 41110436)
25. Gutierrez LS, Schulman A, Brito-Robinson T, Noria F, Ploplis VA, Castellino FJ. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res 60: 5839-5847, 2000.
26. Halperin R, Fleminger G, Kraicer PF, Hadas E. Desmin as an immunochemical marker of human decidual cells and its expression in menstrual fluid. Hum Reprod 6: 186-189, 1991.
27. Hirashima M, Lu Y, Byers L, Rossant J. Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta. Proc Natl Acad Sci USA 100: 15637-15642, 2003. (Pubitemid 38021042)
28. Hu ZY, Liu YX, Liu K, Byrne S, Ny T, Feng Q, Ockleford CD. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. J Anat 194: 183-195, 1999. (Pubitemid 29191837)
29. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264, 2003.
30. Kawai J, Shinagawa A, Shibata K, Yoshino M, Itoh M, Ishii Y, Arakawa T, Hara A, Fukunishi Y, Konno H, Adachi J, Fukuda S, Aizawa K, Izawa M, Nishi K, Kiyosawa H, Kondo S, Yamanaka I, Saito T, Okazaki Y, Gojobori T, Bono H, Kasukawa T, Saito R, Kadota K, Matsuda H, Ashburner M, Batalov S, Casavant T, Fleischmann W, Gaasterland T, Gissi C, King B, Kochiwa H, Kuehl P, Lewis S, Matsuo Y, Nikaido I, Pesole G, Quackenbush J, Schriml LM, Staubli F, Suzuki R, Tomita M, Wagner L, Washio T, Sakai K, Okido T, Furuno M, Aono H, Baldarelli R, Barsh G, Blake J, Boffelli D, Bojunga N, Carninci P, de Bonaldo MF, Brownstein MJ, Bult C, Fletcher C, Fujita M, Gariboldi M, Gustincich S, Hill D, Hofmann M, Hume DA, Kamiya M, Lee NH, Lyons P, Marchionni L, Mashima J, Mazzarelli J, Mombaerts P, Nordone P, Ring B, Ringwald M, Rodriguez I, Sakamoto N, Sasaki H, Sato K, Schonbach C, Seya T, Shibata Y, Storch KF, Suzuki H, Toyo-oka K, Wang KH, Weitz C, Whittaker C, Wilming L, Wynshaw-Boris A, Yoshida K, Hasegawa Y, Kawaji H, Kohtsuki S, Hayashizaki Y. Functional annotation of a full-length mouse cDNA collection. Nature 409: 685-690, 2001.
31. Kobayashi TK, Yakushiji M. Gastric carcinoma metastatic to the bone marrow: immunoperoxidase identification of KMO-1 antigen in MGG-destained aspirate. Diagn Cytopathol 7: 597-600, 1991.
32. Lambert V, Munaut C, Carmeliet P, Gerard RD, Declerck PJ, Gils A, Claes C, Foidart JM, Noel A, Rakic JM. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials. Invest Ophthalmol Vis Sci 44: 2791-2797, 2003. (Pubitemid 36618445)
33. Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM, Rakic JM. Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J 15: 1021-1027, 2001. (Pubitemid 32290790)
34. Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW, Dano K. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 18: 4645-4656, 1999. (Pubitemid 29415519)
35. Maillard C, Bouquet C, Petitjean M, Mestdagt M, Frau E, Jost M, Masset A, Opolon P, Beermann F, Abitbol M, Foidart JM, Perricaudet M, Noel A. Reduction of brain metastases in plasminogen activator inhibitor-1 deficient mice with transgenic ocular tumors. Carcinogenesis 29: 2236-2242, 2008.
36. Maillard C, Jost M, Romer MU, Brunner N, Houard X, Lejeune A, Munaut C, Bajou K, Melen L, Dano K, Carmeliet P, Fusenig NE, Foidart JM, Noel A. Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. Neoplasia 7: 57-66, 2005. (Pubitemid 40209471)
37. Mason RW. Emerging functions of placental cathepsins. Placenta 29: 385-390, 2008.
38. McMahon GA, Petitclerc E, Stefansson S, Smith E, Wong MK, Westrick RJ, Ginsburg D, Brooks PC, Lawrence DA. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem 276: 33964-33968, 2001.
39. Noel A, Maillard C, Rocks N, Jost M, Chabottaux V, Sounni NE, Maquoi E, Cataldo D, Foidart JM. Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol 57: 577-584, 2004. (Pubitemid 38725756)
40. Orwig KE, Ishimura R, Muller H, Liu B, Soares MJ. Identification and characterization of a mouse homolog for decidual/trophoblast prolactin-related protein. Endocrinology 138: 5511-5517, 1997. (Pubitemid 27509716)
41. Pepper MS. Positive and negative regulation of angiogenesis: from cell biology to the clinic. Vasc Med 1: 259-266, 1996. (Pubitemid 27026500)
42. Rakic JM, Lambert V, Devy L, Luttun A, Carmeliet P, Claes C, Nguyen L, Foidart JM, Noel A, Munaut C. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 3186-3193, 2003. (Pubitemid 36759791)
43. Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, Lambert V, Foidart JM, Noel A. Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci 60: 463-473, 2003. (Pubitemid 36459526)
44. Rawn SM, Cross JC. The evolution, regulation, and function of placenta-specific genes. Annu Rev Cell Dev Biol 24: 159-181, 2008.
45. Salamonsen LA. Role of proteases in implantation. Rev Reprod 4: 11-22, 1999. (Pubitemid 29078540)
46. Sartori MT, Serena A, Saggiorato G, Campei S, Faggian D, Pagnan A, Paternoster DM. Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders. J Thromb Haemost 6: 352-358, 2008.
47. Screen M, Dean W, Cross JC, Hemberger M. Cathepsin proteases have distinct roles in trophoblast function and vascular remodelling. Development 135: 3311-3320, 2008.
48. Solberg H, Rinkenberger J, Dano K, Werb Z, Lund LR. A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Development 130: 4439-4450, 2003. (Pubitemid 37185331)
49. Soundararajan R, Rao AJ. Trophoblast "pseudo-tumorigenesis": significance and contributory factors. Reprod Biol Endocrinol 2: 15, 2004.
50. Teesalu T, Blasi F, Talarico D. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development. Dev Dyn 213: 27-38, 1998. (Pubitemid 28394905)
51. Teng YC, Lin QD, Lin JH, Ding CW, Zuo Y. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med 37: 343-348, 2009.
52. Varanou A, Withington SL, Lakasing L, Williamson C, Burton GJ, Hemberger M. The importance of cysteine cathepsin proteases for placental development. J Mol Med 84: 305-317, 2006.
53. von Steinburg SP, Kruger A, Fischer T, Mario Schneider KT, Schmitt M. Placental expression of proteases and their inhibitors in patients with HELLP syndrome. Biol Chem 390: 1199-1204, 2009.
54. Wikstrom AK, Nash P, Eriksson UJ, Olovsson MH. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. Am J Obstet Gynecol 201: 597-598, 2009.